As a result of the development of designer drugs market and its negative consequences, the administration started fighting against their sale. The objective of the audit conducted by NIK was to examine how the responsible state bodies met their obligations in the area, and especially – whether their activities were effective. In relation to some of the issues identified as a result of the audit, we can talk about the expansion of the designer drugs market, since the conditions in which state bodies operate have been changing rapidly. This is especially related to administrative fines for placing designer drugs on the market, and the opportunity to subject activities related to the sale of these products to the law as it stands (de lege lata) criminal responsibility.
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.